Literature DB >> 11410865

Expression of caspases-3, -6 and -8 and their relation to apoptosis in non-small cell lung carcinoma.

U Törmänen-Näpänkangas1, Y Soini, K Kahlos, V Kinnula, P Pääkkö.   

Abstract

We analyzed a set of 103 non-small cell lung carcinomas (NSCLCs) for caspase-3, -6 and -8 expression and apoptosis. Additionally, the expression of bcl-2, bax and p53 were studied. Caspase-3 positivity appeared as diffuse, cytoplasmic staining and was restricted to the tumor area. In contrast, the immunoreactivity for caspase-6 was intense, granular and mostly located in single cells or groups of tumor cells showing apoptotic morphology. The caspase-8 expression pattern was a combination of the two other caspases studied, featuring both diffuse and single-cell patterns restricted to the tumor area. No significant differences were seen in caspase -3, -6 and -8 expression between tumors of different histological types or grades. The number of apoptotic cells and bodies was significantly higher in NSCLCs, in which caspase-8 immunostaining was mainly seen in single cells (p = 0.017), whereas caspase -3 and -6 expression had no association with apoptosis. It is apparent that, in lung tissue, up-regulation of caspase expression is a phenomenon associated solely with neoplasia and reflects the readiness of the tumor cells to undergo apoptosis. Interestingly, caspases -3, -6 and -8 each have an individual staining pattern in NSCLC, perhaps reflecting their different position in the caspase hierarchy. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410865     DOI: 10.1002/ijc.1315

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Immunohistochemical analysis of pro- and active-caspase 3 in laryngeal squamous cell carcinoma.

Authors:  Andrej Cör; Joze Pizem; Nina Gale
Journal:  Virchows Arch       Date:  2004-03-25       Impact factor: 4.064

2.  Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1).

Authors:  Danny C Hsu; Howard S Roth; Diana C West; Rachel C Botham; Chris J Novotny; Steven C Schmid; Paul J Hergenrother
Journal:  ACS Comb Sci       Date:  2011-10-28       Impact factor: 3.784

3.  Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics.

Authors:  Howard S Roth; Rachel C Botham; Steven C Schmid; Timothy M Fan; Levent Dirikolu; Paul J Hergenrother
Journal:  J Med Chem       Date:  2015-04-20       Impact factor: 7.446

4.  A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.

Authors:  Xiaoxiang Guan; Zhensheng Liu; Hongliang Liu; Hongping Yu; Li-E Wang; Erich M Sturgis; Guojun Li; Qingyi Wei
Journal:  FASEB J       Date:  2012-12-27       Impact factor: 5.191

5.  Effect of small interfering RNA transfection on FAK and DLC1 mRNA expression in OVCAR-3.

Authors:  Huirong Shi; Huina Liu; Guoqiang Zhao
Journal:  Mol Biol Rep       Date:  2012-07-04       Impact factor: 2.316

6.  CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck.

Authors:  Kexin Chen; Hui Zhao; Zhibin Hu; Li-E Wang; Wei Zhang; Erich M Sturgis; Qingyi Wei
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

7.  Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer.

Authors:  Zhiwei Wu; Ye Li; Shuying Li; Lin Zhu; Guangxiao Li; Zhifu Yu; Xiaojuan Zhao; Jie Ge; Binbin Cui; Xinshu Dong; Suli Tian; Fulan Hu; Yashuang Zhao
Journal:  Med Oncol       Date:  2013-05-29       Impact factor: 3.064

8.  Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells.

Authors:  Yi-Feng Wu; Ming-Fu Cao; Yan-Ping Gao; Fei Chen; Tao Wang; Edward P Zumbika; Kai-Xian Qian
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

9.  Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.

Authors:  Howard S Roth; Paul J Hergenrother
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

10.  Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand.

Authors:  Liu-Qin Yang; Dian-Chun Fang; Rong-Quan Wang; Shi-Ming Yang
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.